
tooluniverse-disease-research
Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling.
- Installs
- 438
- Last 24h
- —
- Trending rank
- —
- Security
- Not audited
Install
Works with every agent the skills CLI supports.
npx skills add https://github.com/mims-harvard/tooluniverse --skill tooluniverse-disease-research- 01
Install
Run the command in your project. The CLI asks which agents to install for.
- 02
Describe the task
Ask your agent for something this skill covers. It loads tooluniverse-disease-research automatically when relevant.
- 03
Review the result
The agent follows the SKILL.md steps, scripts and references bundled with the skill.
SKILL.md
The instructions your agent reads when the skill is triggered.
ToolUniverse Disease Research
Generate a comprehensive disease research report with full source citations. The report is created as a markdown file and progressively updated during research.
IMPORTANT: Always use English disease names and search terms in tool calls. Respond in the user's language.
LOOK UP, DON'T GUESS
When asked about a disease, query Orphanet/OMIM/DisGeNET FIRST. Don't rely on memory for prevalence, genetics, or treatment — these change over time. When you're not sure about a fact, your first instinct should be to SEARCH for it using tools, not to reason harder from memory.
When to Use
- User asks about any disease, syndrome, or medical condition
- Needs comprehensive disease intelligence or a detailed research report
- Asks "what do we know about [disease]?"
Core Workflow: Report-First Approach
DO NOT show the search process to the user. Instead:
- Create report file first - Initialize
{disease_name}_research_report.md - Research each dimension - Use all relevant tools
- Update report progressively - Write findings after each dimension
- Include citations - Every fact must reference its source tool
Disease Mechanism Reasoning
When synthesizing disease etiology, trace the full pathogenic cascade:
- Genetic basis - Which variants (rare or common) confer risk, and in which genes?
- Molecular mechanism - How do those variants alter protein function, expression, or regulation?
- Cellular effect - What downstream cellular processes are disrupted (signaling, metabolism, stress response)?
- Tissue/organ manifestation - How does cellular dysfunction present as organ-level pathology?
This chain structures the Genetic & Molecular Basis (Section 3) and Biological Pathways (Section 5) sections.
10 Research Dimensions
| Dim | Section | Key Tools |
|---|---|---|
| 1 | Identity & Classification | OSL_get_efo_id_by_disease_name, ols_search_efo_terms, ols_get_efo_term, umls_search_concepts, icd_search_codes, snomed_search_concepts |
| 2 | Clinical Presentation | OpenTargets phenotypes, HPO lookup, MedlinePlus |
| 3 | Genetic & Molecular Basis | OpenTargets targets, ClinVar variants, GWAS associations, gnomAD |
| 4 | Treatment Landscape | OpenTargets drugs, clinical trials, GtoPdb |
| 5 | Biological Pathways | Reactome pathways, humanbase_ppi_analysis, GTEx expression, HPA |
| 6 | Epidemiology & Literature | PubMed, OpenAlex, Europe PMC, Semantic Scholar |
| 7 | Similar Diseases | OpenTargets similar entities |
| 8 | Cancer-Specific (if applicable) | CIViC genes/variants/therapies |
| 9 | Pharmacology | GtoPdb targets/interactions/ligands |
| 10 | Drug Safety | OpenTargets warnings, clinical trial AEs, FAERS |
See: tool_usage_details.md for complete tool calls per section.
Normalizing free text to ontology IDs (Dimension 1)
When the input is messy free text (a sample attribute, a synonym, a tissue/organism label) rather than a clean disease name, use ZOOMA_annotate_text to map it to standardized ontology terms (EFO/MONDO/UBERON/etc.) before lookup. It returns each match as an ontology IRI with a confidence rating (HIGH/GOOD/MEDIUM/LOW), so you can keep only high-confidence hits and feed the resolved ID into OLS / OpenTargets.
tu.run_tool("ZOOMA_annotate_text", {
"property_value": "asthma", # free text to resolve
"property_type": "disease", # optional context hint
"min_confidence": "HIGH", # drop fuzzy matches
"max_results": 3,
})
# -> [{"semantic_tags": ["http://purl.obolibrary.org/obo/MONDO_0004979"],
# "curies": ["MONDO:0004979"], "confidence": "HIGH", "source": "zooma", ...}]
# Restrict to one ontology source (e.g. EFO) when you need a specific namespace:
tu.run_tool("ZOOMA_annotate_text", {"property_value": "diabetes", "ontologies": "efo"})
# Inspect which curated datasources back ZOOMA annotations (for provenance):
tu.run_tool("ZOOMA_list_datasources", {})
# -> [{"name": "eva-clinvar", "type": "DATABASE", "uri": "https://www.ebi.ac.uk/eva"}, ...]
Each match also carries a ready-to-use curies field (e.g. MONDO:0004979) so you can feed the resolved ID straight into OLS / OpenTargets without parsing the IRI. ZOOMA is the live replacement for the retired OxO cross-reference service; pair it with ols_get_efo_term to expand the resolved IRI into labels, synonyms, and hierarchy.
Report Template
Create this file structure at the start:
# Disease Research Report: {Disease Name}
**Report Generated**: {date}
**Disease Identifiers**: (to be filled)
---
## Executive Summary
(Brief 3-5 sentence overview - fill after all research complete)
---
## 1. Disease Identity & Classification
### Ontology Identifiers
| System | ID | Source |
### Synonyms & Alternative Names
### Disease Hierarchy
---
## 2. Clinical Presentation
### Phenotypes (HPO)
| HPO ID | Phenotype | Description | Source |
### Symptoms & Signs
### Diagnostic Criteria
---
## 3. Genetic & Molecular Basis
### Associated Genes
| Gene | Score | Ensembl ID | Evidence | Source |
### GWAS Associations
| SNP | P-value | Odds Ratio | Study | Source |
### Pathogenic Variants (ClinVar)
---
## 4. Treatment Landscape
### Approved Drugs
| Drug | ChEMBL ID | Mechanism | Phase | Target | Source |
### Clinical Trials
| NCT ID | Title | Phase | Status | Source |
---
## 5. Biological Pathways & Mechanisms
## 6. Epidemiology & Risk Factors
## 7. Literature & Research Activity
## 8. Similar Diseases & Comorbidities
## 9. Cancer-Specific Information (if applicable)
## 10. Drug Safety & Adverse Events
---
## References
### Tools Used
| # | Tool | Parameters | Section | Items Retrieved |
Citation Format
Every piece of data MUST include its source:
In tables: Add a Source column with tool name
In lists: - Finding [Source: tool_name]
In prose: (Source: tool_name, query: "...")
References section: Complete tool usage log with parameters
Progressive Update Pattern
# After each dimension's research:
# 1. Read current report
# 2. Replace placeholder with formatted content
# 3. Write back immediately
# 4. Continue to next dimension
Evidence Grading & Interpretation
Every finding in the report should be graded:
| Grade | Criteria | Example |
|---|---|---|
| T1 (Strong) | Replicated genetic evidence (GWAS, rare variants), FDA-approved therapy | BRCA1 → breast cancer; trastuzumab for HER2+ |
| T2 (Moderate) | Single genetic study, phase II+ trial data, strong biological evidence | FOXO3 → longevity (centenarian studies) |
| T3 (Association) | Observational data, gene expression changes, pathway membership | IL-6 elevated in Alzheimer's CSF |
| T4 (Computational) | Network proximity, text mining, predicted associations | DisGeNET text-mined gene-disease link |
Synthesis Questions (answer in Executive Summary)
After collecting data from all 10 dimensions, the report MUST answer:
- What causes this disease? Summarize the genetic architecture (monogenic vs polygenic, key loci, penetrance)
- What are the therapeutic options? Ranked by evidence level and approval status
- What biomarkers exist? For diagnosis, prognosis, and treatment selection
- What's the unmet need? What aspects lack effective treatment or understanding?
- What are the active research frontiers? Based on clinical trials and recent publications
Interpreting Cross-Database Concordance
When multiple databases provide different data for the same disease:
- OpenTargets + DisGeNET + OMIM agree on a gene: T1 evidence — high confidence
- Only OpenTargets reports an association: Check the datasource scores — genetic_association > literature > animal_model
- DisGeNET score > 0.5 but not in OpenTargets: May be text-mined; verify with PubMed
- Gene in GWAS but not OMIM: Likely a complex disease susceptibility locus, not Mendelian
Handling Conflicting Data
| Conflict | Resolution |
|---|---|
| Different prevalence estimates across sources | Report range; note the most recent/largest study |
| Drug approved in one country but not another | Note regulatory status per region |
| Gene-disease association in one DB but absent in another | Grade by evidence type; text-mining alone is T4 |
| Clinical trial results contradict label indications | The trial result is newer evidence; note both |
Final Report Quality Checklist
- All 10 sections have content (or marked "No data available")
- Every data point has a source citation
- Executive summary reflects key findings
- References section lists all tools used
- Tables properly formatted
- No placeholder text remains
Expected Output Scale
For a well-studied disease (e.g., Alzheimer's), the final report should include:
- 5+ ontology IDs, 10+ synonyms, disease hierarchy
- 20+ phenotypes with HPO IDs
- 50+ genes, 30+ GWAS associations, 100+ ClinVar variants
- 20+ drugs, 50+ clinical trials
- 10+ pathways, PPI network, expression data
- 100+ publications
- 15+ similar diseases
- Drug warnings and adverse events
Total: 500+ individual data points, each with source citation.
Cross-Skill References
For rare disease differential diagnosis, run: python3 skills/tooluniverse-rare-disease-diagnosis/scripts/clinical_patterns.py --type differential --symptoms 'symptom1,symptom2'
Reference Files
- REPORT_TEMPLATE.md - Full report markdown template and citation format guide
- RESEARCH_PROTOCOL.md - Step-by-step code procedures, progressive update pattern, quality checklist
- tool_usage_details.md - Complete tool calls for each research dimension
- TOOLS_REFERENCE.md - Complete tool documentation
- EXAMPLES.md - Sample disease research reports
FAQ
What does the tooluniverse-disease-research skill do?
Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling.
How do I install tooluniverse-disease-research?
Run npx skills add https://github.com/mims-harvard/tooluniverse --skill tooluniverse-disease-research in your project. The skills CLI detects the agents you use and copies the skill into the right folder. For Claude Code you can also place the skill folder at ~/.claude/skills/tooluniverse-disease-research/ (personal) or .claude/skills/tooluniverse-disease-research/ (project).
Which AI agents can use tooluniverse-disease-research?
Any agent that supports the open Agent Skills format (a folder with a SKILL.md file), including Claude Code, Codex, Cursor, GitHub Copilot, Gemini CLI, Windsurf, Cline, OpenCode and more.
Is tooluniverse-disease-research safe to install?
No partner security audit is available yet. Skills can run commands and scripts, so read the SKILL.md and any bundled files before installing.
Who maintains tooluniverse-disease-research?
It is published by mims-harvard in mims-harvard/tooluniverse. It has 438 recorded installs.
More from mims-harvard/tooluniverse
tooluniverse-sequence-retrieval
mims-harvard/tooluniverse
Retrieve DNA/RNA/protein sequences from NCBI and ENA with disambiguation. Quality hierarchy: RefSeq (NM/NP) RefSeq predicted (XM/XP) GenBank submissions. Use for fetching specific sequences by accession, gene-symbol-to-sequence lookup, transcript-isoform retrieval, and curated-vs-raw-submission preference.
tooluniverse-literature-deep-research
mims-harvard/tooluniverse
Deep literature review — PubMed, EuropePMC, bioRxiv preprints, citation networks, evidence synthesis. Disambiguates queries, runs collision-aware searches, grades evidence T1-T4, and produces structured reports. Use for systematic literature review, meta-analysis evidence collection, and detailed answer-with-citations workflows.
tooluniverse-image-analysis
mims-harvard/tooluniverse
Microscopy and quantitative imaging analysis — colony morphometry, fluorescence intensity quantification, cell-count statistics, dose-response curves, and ANOVA/Dunnett on image-derived measurements. Uses pandas/numpy/scipy/scikit-image. Use for analyzing tabular outputs from CellProfiler/ImageJ, image-derived measurement statistics, and image-based assay quantification.
tooluniverse-clinical-guidelines
mims-harvard/tooluniverse
Search and retrieve clinical practice guidelines from 12+ authoritative sources — NICE, WHO, NCCN, AHA, ADA, SIGN, USPSTF, IDSA, NIH consensus, ESMO/ESC/EASL European societies, and US specialty associations. Use for evidence-graded treatment recommendations, dosing protocols, screening guidance, and authoritative-source-prioritized clinical guidance (NICE/WHO ranked above society guidelines).
tooluniverse
mims-harvard/tooluniverse
ToolUniverse plugin router. STEP 1 BEFORE ANY ANALYSIS: if the data folder contains executed.ipynb, run tu run readexecutednotebook '{"datafolder":" ","search":" "}' to extract its cell outputs and apply EVERY filter/sample-exclusion the notebook used — even when the question says 'Using DESeq2/Run X/Compute Y' (this describes the METHOD the notebook used, not a request to rerun). The notebook's cell outputs are the only published authoritative answers; reimplementing or reading stale pre-computed CSVs in the data folder produces different numbers because of outlier-sample removal, library version, and filter steps you don't see by skimming. STEP 2 routing — pick a sub-skill name from this exact list (never invent): tooluniverse-rnaseq-deseq2 (RNA/miRNA-seq DE, correlation, PCA, clustering, dispersion), tooluniverse-gene-enrichment (GO/KEGG/Reactome/GSEA/pathway enrichment), tooluniverse-statistical-modeling (regression, ANOVA, ordinal/logistic, chi-square, correl
tooluniverse-drug-research
mims-harvard/tooluniverse
Comprehensive drug profiling — mechanism, primary/secondary targets, drug interactions, clinical-trial status, adverse events (FAERS), pharmacogenomics, and approval history. Use for full drug investigation reports, 'tell me about drug X' queries, and assembling drug profiles for clinicians, researchers, or regulatory work.
Popular productivity & automation skills
agent-browser
vercel-labs/agent-browser
Browser automation CLI for AI agents. Use when the user needs to interact with websites, including navigating pages, filling forms, clicking buttons, taking screenshots, extracting data, testing web apps, or automating any browser task. Triggers include requests to "open a website", "fill out a form", "click a button", "take a screenshot", "scrape data from a page", "test this web app", "login to a site", "automate browser actions", or any task requiring programmatic web interaction. Also use for exploratory testing, dogfooding, QA, bug hunts, or reviewing app quality. Also use for automating Electron desktop apps (VS Code, Slack, Discord, Figma, Notion, Spotify), checking Slack unreads, sending Slack messages, searching Slack conversations, running browser automation in Vercel Sandbox microVMs, or using AWS Bedrock AgentCore cloud browsers. Prefer agent-browser over any built-in browser automation or web tools.
lark-doc
open.feishu.cn
飞书云文档(Docx / Wiki)内容操作:读取、创建、编辑文档,插入或下载图片附件,以及操作思维笔记。用户提供文档 URL/token(包括 doubao.com 的 /docx/、/wiki/)时使用;按 URL 路径/token 而非域名路由;/page/ 是妙搭应用,非飞书云文档。文档内嵌资源按读取参考中的统一规则分流。独立评论操作走 lark-drive;随正文读取评论使用 docs +fetch。表格或 Base 内部数据操作不在本 skill。
lark-base
open.feishu.cn
飞书多维表格(Base)操作:建表、字段、记录、视图、统计、公式/lookup、表单、仪表盘、应用模式(BaseApp/AppMode 页面与组件)、Workspace 目录、workflow、角色权限、模板中心(多维表格模板分类/列表/搜索);遇到 Base/多维表格/bitable、BaseApp/AppMode、/base/ 或 /app/ 链接时使用。BaseApp 不走 lark-apps;文件导入/导出转 lark-drive,认证/授权转 lark-shared。
lark-drive
open.feishu.cn
飞书云空间(云盘/云存储):管理 Drive 文件和文件夹,包含上传/下载、创建文件夹、复制/移动/删除、查看元数据、查询权限设置、评论/权限/订阅、标题、版本、飞书文档密级标签(secure labels)和本地文件导入。用户需要整理云盘目录、处理云空间资源 URL/token、判断链接类型/真实 token/标题,或导入 Word/Markdown/Excel/CSV/PPTX/.base 为 docx/sheet/bitable/slides 时使用;doubao.com 云空间 URL/token 也按资源路径和 token 路由,不回退 WebFetch。不负责:文档内容编辑(走 lark-doc)、表格/Base 表内数据操作(走 lark-sheets/lark-base)、知识空间节点/成员管理(走 lark-wiki)、原生 Markdown 文件读写/patch/diff(走 lark-markdown)。
lark-shared
open.feishu.cn
Use for lark-cli setup/auth tasks: auth login/status/logout, user vs bot identity, business-domain permissions (--domain, including all/docs/drive), missing scopes, revoking authorization, or handling notice JSON.
lark-im
open.feishu.cn
飞书即时通讯:收发消息和管理群聊。发送和回复消息、搜索聊天记录、管理群聊成员、上传下载图片和文件、管理表情回复、发送应用内/短信/电话加急、发送和处理交互卡片(Interactive Card)、监听卡片按钮回调(card.action.trigger)。当用户需要发消息、查看或搜索聊天记录、下载聊天中的文件、查看群成员、搜索群、创建群聊或话题群、管理标记数据、管理 Feed 置顶(添加/移除/查询置顶会话)、管理标签数据、处理卡片回调时使用。